Author: admin

Multiple Myeloma Market Trends 2032: Epidemiology, Market Size, Therapies, Clinical Trials, Companies, and Growth Analysis by DelveInsight. Segmented by Therapies and Countries | GSK, Amgen, Takeda

“Multiple Myeloma Market”

(New York, USA) DelveInsight’s “Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Multiple Myeloma, historical and forecasted epidemiology as well as the Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Multiple Myeloma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Multiple Myeloma market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Multiple Myeloma treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Multiple Myeloma market.

 

Request for a Free Sample Report @ Multiple Myeloma Market Forecast

 

Some facts of the Multiple Myeloma Market Report are:

  • According to DelveInsight, Multiple Myeloma market is expected to grow at a decent CAGR by 2032.
  • Leading Multiple Myeloma companies working in the market are GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen (Onyx therapeutics), Takeda Pharmaceutical, Millennium Pharmaceuticals, Sanofi, Karyopharm Therapeutic, Janssen Biotech, Bristol Myers Squibb, AbbVie, Takeda Pharmaceutical, Janssen Pharmaceutical, Bristol-Myers Squibb Company (Celgene), RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Aduro Biotech, ExCellThera, Precision BioSciences, Takeda, Glenmark (Ichnos Sciences SA), Poseida Therapeutics, Molecular Partners, Chipscreen Biosciences, Nanjing Legend Biotech, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Cartesian Therapeutics, AstraZeneca, MorphoSys AG/I-Mab Biopharma and others.
  • Key Multiple Myeloma Therapies expected to launch in the market are Venetoclax (ABT-199), Ciltacabtagene Autoleucel (cilta-cel/ JNJ-4528/ JNJ-68284528/ LCAR-B38M), REGN5458, Iberdomide (CC-220), Blenrep (Belantamab Mafodotin /GSK2857916), Abecma (Idecabtagene vicleucel/bb2121/ ide-cel), Pepaxto (melflufen/ melphalan flufenamide), Sarclisa (Isatuximab), Xpovio (Selinexor), Darzalex (Daratumumab) and others.

 

Multiple Myeloma Overview

Multiple myeloma is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow. These malignant cells crowd out healthy blood-forming cells, leading to bone marrow dysfunction, anemia, and weakened immunity. Common symptoms include bone pain, fatigue, renal complications, and hypercalcemia. The disease’s intricate pathogenesis involves genetic alterations, immune dysregulation, and interactions with the bone microenvironment. Treatment approaches encompass chemotherapy, immunomodulatory drugs, proteasome inhibitors, stem cell transplantation, and emerging targeted therapies. Despite advancements, multiple myeloma remains incurable, requiring a multimodal approach for disease management and improved patient outcomes. Ongoing research seeks to elucidate its underlying mechanisms, refine therapeutic strategies, and develop novel agents to enhance patients’ quality of life and extend survival.

 

Learn more about Multiple Myeloma treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/multiple-myeloma-market

 

Multiple Myeloma Market 

The Multiple Myeloma market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Multiple Myeloma market trends by analyzing the impact of current Multiple Myeloma therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Multiple Myeloma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Multiple Myeloma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Multiple Myeloma market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Multiple Myeloma Epidemiology 

The Multiple Myeloma epidemiology section provides insights into the historical and current Multiple Myeloma patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Multiple Myeloma market report also provides the diagnosed patient pool, trends, and assumptions. 

 

Explore more about Multiple Myeloma Epidemiology @ https://www.delveinsight.com/sample-request/multiple-myeloma-market

 

Multiple Myeloma Drugs Uptake

This section focuses on the uptake rate of the potential Multiple Myeloma drugs recently launched in the Multiple Myeloma market or expected to be launched in 2019-2032. The analysis covers the Multiple Myeloma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Multiple Myeloma Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Multiple Myeloma market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Multiple Myeloma Pipeline Development Activities

  • Venetoclax (ABT-199): AbbVie and Roche
  • JNJ-68284528 (LCAR-B38M/JNJ-4528): Janssen Biotech/Nanjing Legend Biotech
  • Keytruda (Pembrolizumab): Merck Sharp & Dohme Corp.
  • Cetrelimab (JNJ-63723283): Janssen Research & Development
  • REGN5458: Regeneron Pharmaceuticals
  • Felzartamab (MOR202): MorphoSys AG/I-Mab Biopharma
  • Chidamide (Epidaza): Chipscreen Biosciences
  • Iberdomide (CC-220): Bristol-Myers Squibb/Celgene
  • Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy: RAPA Therapeutics
  • Encorafenib in combination with Binimetinib: Pfizer (Array Biopharma)
  • CLR 131 (131-CLR1404): Cellectar Biosciences
  • BL-8040: BioLineRx
  • GVAX (GM-CSF) Vaccine: Celgene/Aduro Biotech
  • ECT-001: ExCellThera
  • TAK-079: Takeda
  • GBR 1342 (ISB 1342): Glenmark (Ichnos Sciences SA)
  • P-BCMA-101 CAR-T cells: Poseida Therapeutics
  • Opdivo (Nivolumab): Bristol-Myers Squibb
  • PBCAR269A: Precision BioSciences
  • MP0250: Molecular Partners AG
  • Teclistamab (JNJ-7957; JNJ-64007957): Janssen Pharmaceutical
  • Descartes-11: Cartesian Therapeutics
  • Imfinzi (Durvalumab): AstraZeneca
  • Imbruvica (Ibrutinib): Abbvie (Pharmacyclics) and Johnson & Johnson

 

Request for a sample report to understand more about the Multiple Myeloma pipeline development activities @ https://www.delveinsight.com/sample-request/multiple-myeloma-market

 

Multiple Myeloma Therapeutics Assessment

Major key companies are working proactively in the Multiple Myeloma Therapeutics market to develop novel therapies which will drive the Multiple Myeloma treatment markets in the upcoming years are GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen (Onyx therapeutics), Takeda Pharmaceutical, Millennium Pharmaceuticals, Sanofi, Karyopharm Therapeutic, Janssen Biotech, Bristol Myers Squibb, AbbVie, Takeda Pharmaceutical, Janssen Pharmaceutical, Bristol-Myers Squibb Company (Celgene), RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Aduro Biotech, ExCellThera, Precision BioSciences, Takeda, Glenmark (Ichnos Sciences SA), Poseida Therapeutics, Molecular Partners, Chipscreen Biosciences, Nanjing Legend Biotech, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Cartesian Therapeutics, AstraZeneca, MorphoSys AG/I-Mab Biopharma and others.

 

Learn more about the emerging Multiple Myeloma therapies & key companies @ https://www.delveinsight.com/sample-request/multiple-myeloma-market

 

Multiple Myeloma Report Key Insights

1. Multiple Myeloma Patient Population

2. Multiple Myeloma Market Size and Trends

3. Key Cross Competition in the Multiple Myeloma Market

4. Multiple Myeloma Market Dynamics (Key Drivers and Barriers)

5. Multiple Myeloma Market Opportunities

6. Multiple Myeloma Therapeutic Approaches

7. Multiple Myeloma Pipeline Analysis

8. Multiple Myeloma Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Multiple Myeloma Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Multiple Myeloma Competitive Intelligence Analysis

4. Multiple Myeloma Market Overview at a Glance

5. Multiple Myeloma Disease Background and Overview

6. Multiple Myeloma Patient Journey

7. Multiple Myeloma Epidemiology and Patient Population

8. Multiple Myeloma Treatment Algorithm, Current Treatment, and Medical Practices

9. Multiple Myeloma Unmet Needs

10. Key Endpoints of Multiple Myeloma Treatment

11. Multiple Myeloma Marketed Products

12. Multiple Myeloma Emerging Therapies

13. Multiple Myeloma Seven Major Market Analysis

14. Attribute Analysis

15. Multiple Myeloma Market Outlook (7 major markets)

16. Multiple Myeloma Access and Reimbursement Overview

17. KOL Views on the Multiple Myeloma Market

18. Multiple Myeloma Market Drivers

19. Multiple Myeloma Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Multiple Myeloma Market Trends 2032: Epidemiology, Market Size, Therapies, Clinical Trials, Companies, and Growth Analysis by DelveInsight. Segmented by Therapies and Countries | GSK, Amgen, Takeda

GlaxoSmithKline’s “Benlysta (belimumab) market size expected to increase many folds by 2030, report DelveInsight

“Benlysta (belimumab) Market”

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Benlysta (GlaxoSmithKline) providing insights into the drug market landscape and market forecast of Benlysta upto 2030. The report, titled “Benlysta (belimumab) – Market Size, Forecast, and Drug Insight – 2030” is now available for review and analysis.

Are you interested in finding out the projected market size of Benlysta in 2030? Click @ Benlysta Market Size

The Benlysta Market Report offers projected sales forecasts for Benlysta for indications until 2030, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.

BENLYSTA Overview:

BENLYSTA (belimumab) is a fully-humanized monoclonal antibody administered through both intravenous and subcutaneous routes. This antibody effectively binds to and deactivates B-lymphocyte stimulator, a cytokine expressed by B-cell lineage cells. This cytokine is responsible for activating B cells, promoting their proliferation, and inducing differentiation. By inhibiting B-lymphocyte proliferation and differentiation, BENLYSTA becomes the first and only biologic approved for treating both systemic lupus erythematosus (SLE), a chronic autoimmune disease, and lupus nephritis (LN), the kidney inflammation associated with lupus.

Functioning as a BLyS-specific inhibitor, BENLYSTA hinders the binding of soluble BLyS, a B-cell survival factor, to its receptors on B cells. Although it does not directly bind to B cells, BENLYSTA’s interaction with BLyS prevents the survival of B cells, including autoreactive ones. Additionally, it reduces the differentiation of B cells into plasma cells that produce immunoglobulins.

Do you know your drug’s competitive positioning against Benlysta? Download Report: Benlysta Market Dynamics

GlaxoSmithKline’s Benlysta is serving as a beacon of hope for the patients suffering from the Lupus Nephritis.

Benlysta (belimumab) is a human IgG1λ monoclonal antibody specific for B-lymphocyte stimulator (BLyS)-specific inhibitor specified for the treatment of adult active lupus nephritis patients as well as SLE patients aged 5 years and older, who are receiving standard therapy. In SLE it is indicated for the treatment of patients aged 5 years and older with active, autoantibody-positive, SLE who are receiving standard therapy. It is a BLyS-specific inhibitor that blocks the binding of soluble BLyS, a B-cell survival factor, to its receptors on B cells. It does not bind B cells directly, but by binding BLyS, it inhibits the survival of B cells, including autoreactive B cells, and helps reduce the differentiation of B cells into immunoglobulin-producing plasma cells.

Benlysta is provided as a lyophilized powder (120 mg or 400 mg) in a single-use vial for intravenous infusion and should be reconstituted and diluted by aseptic technique. The recommended dosage of Benlysta is 10 mg/kg at 2-week intervals for the first three doses and at 4-week intervals thereafter reconstitute, dilute and administer as an intravenous infusion only, for 1 h. The Benlysta intravenous formulation is licensed for use in over 70 countries worldwide, including the US, Japan, and EU countries. It may be administered as an intravenous infusion in patients aged 5 years and older or as a subcutaneous injection in patients aged 18 years and older.

Moreover, European Commission has approved the expanded use of intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for the treatment of adult patients with active LN in Europe.

The report extensively covers the details and developments related to Benlysta, capturing important highlights on developmental pipeline, regulatory status and special designations of Benlysta, route of administration, safety and efficacy details.

Benlysta Market Assessment

This Benlysta market report provides a detailed market assessment of Benlysta for Lupus Nephritis in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2030.

Benlysta Clinical Assessment

The Benlysta market report provides the clinical trials information of Benlysta for Lupus Nephritis covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related. 

Benlysta Competitive Landscape 

The Benlysta market report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the Benlysta.

Benlysta Market Size in the US

A dedicated section of the report focuses on the expected market size of Benlysta for the United States. DelveInsight’s analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.

What is a Benlysta Prescribed for?

Benlysta is prescribed for the treatment of Lupus Nephritis.

Request for Sample Report @ https://www.delveinsight.com/sample-request/benlysta-belimumab-drug-insight-market-forecast

Key Highlights of Benlysta: 

  • The report contains forecasted sales of Benlysta for indication till 2030.
  • Comprehensive coverage of the late-stage emerging therapies for Lupus Nephritis.
  • The report also features the qualitative and quantitative analysis with analysts as well as KOL views for Benlysta in Lupus Nephritis.

Why you should buy Benlysta Market Report:

  • The report provides future market assessments for Benlysta for Lupus Nephritis in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts’ views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
  • Leading Benlysta for Lupus Nephritis forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the Benlysta 
  • Discover the competitive landscape of Benlysta through 7MM
  • Get a Thorough Analysis of the Benlysta Development pipeline, Safety & Efficacy of the Benlysta, and ROA
  • Thorough Benlysta market forecast will help understand how drug is competing with other emerging Benlysta
  • Get analysis of the Benlysta clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
  • Drug Market forecasts are calculated after taking into consideration KOL viewpoints

Related Reports By DelveInsight:

Lupus Nephritis Market

DelveInsight’s Lupus Nephritis Market Insights, Epidemiology, and Market Forecast 2032’ report delivers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Lupus Nephritis Pipeline

DelveInsight’s, “Lupus Nephritis Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: GlaxoSmithKline’s “Benlysta (belimumab) market size expected to increase many folds by 2030, report DelveInsight

AstraZeneca’s SAPHNELO market size expected to increase many folds by 2032, report DelveInsight

“SAPHNELO market”

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on SAPHNELO (AstraZeneca) providing insights into the drug market landscape and market forecast of SAPHNELO upto 2032. The report, titled “SAPHNELO Market Size, Forecast, and Emerging Insight – 2032” is now available for review and analysis.

 

Are you interested in finding out the projected market size of SAPHNELO in 2032? Click @ SAPHNELO Market Size

 

The SAPHNELO Market Report offers projected sales forecasts for SAPHNELO for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.

 

SAPHNELO Overview:

AstraZeneca’s SAPHNELO is serving as a beacon of hope for the patients suffering from the Lupus Nephritis.

SAPHNELO (anifrolumab), developed by AstraZeneca, is an intravenously administered, fully humanmonoclonal antibody that binds to subunit 1 of the type I IFN receptor, blocking the activity of type IIFN. Type I IFNs, such as IFN-alpha, IFN-beta, and IFN-kappa, are cytokines involved in regulating theinflammatory pathways. Anifrolumab induces rapid internalization of IFNAR1 from the surface ofmonocytes, thereby reducing heterodimerization with IFNAR2 and the setting up of the IFN signalingcomplex. By antagonizing the binding of the different IFNs to the IFNAR1 receptor, anifrolumab blocksSTAT1 phosphorylation and IFN-stimulated response element (ISRE) activity. SAPHNELO is alreadyapproved for the treatment of adult patients with moderate to severe systemic lupus erythematosus(SLE). Saphnelo is approved to treat SLE in more than 60 countries worldwide including the US, EU and Japan,with reviews ongoing in other countries.

The report extensively covers the details and developments related to SAPHNELO, capturing important highlights on developmental pipeline, regulatory status and special designations of SAPHNELO, route of administration, safety and efficacy details.

 

Do you know your drug’s competitive positioning against SAPHNELO? Download Report: SAPHNELO Market Dynamics

 

SAPHNELO Market Assessment

This report provides a detailed market assessment of SAPHNELO for Lupus Nephritis in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.

 

SAPHNELO Clinical Assessment

The report provides the clinical trials information of SAPHNELO for Lupus Nephritis covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related.

  • SAPHNELO continues to be evaluated in the TULIP-SC Phase III trial assessing subcutaneous deliveryin SLE, and the IRIS Phase III trial in active proliferative lupus nephritis.
  • Additional Phase III trials are planned investigating SAPHNELO in diseases where type I IFN plays akey role, including cutaneous lupus erythematosus, systemic sclerosis and myositis.

 

SAPHNELO Competitive Landscape 

The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the SAPHNELO.

 

SAPHNELO Market Size in the US

A dedicated section of the report focuses on the expected market size of SAPHNELO for the United States. DelveInsight’s analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.

 

What is a SAPHNELO Prescribed for?

SAPHNELO is prescribed for the treatment of Lupus Nephritis.

 

Key Highlights of SAPHNELO:

  • The report contains forecasted sales of SAPHNELO for indication till 2032.
  • Comprehensive coverage of the late-stage emerging therapies for Lupus Nephritis.
  • The report also features the qualitative and quantitative analysis with analysts as well as KOL views for SAPHNELO in Lupus Nephritis.

 

Request for Sample Page @ https://www.delveinsight.com/sample-request/saphnelo-emerging-drug-insight-and-market-forecast

 

Why you should buy SAPHNELO Market Report:

  • The report provides future market assessments for SAPHNELO for Lupus Nephritis in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts’ views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
  • Leading SAPHNELO for Lupus Nephritis forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the SAPHNELO 
  • Discover the competitive landscape of SAPHNELO through 7MM
  • Get a Thorough Analysis of the SAPHNELO Development pipeline, Safety & Efficacy of the SAPHNELO, and ROA
  • Thorough SAPHNELO market forecast will help understand how drug is competing with other emerging SAPHNELO
  • Get analysis of the SAPHNELO clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
  • Drug Market forecasts are calculated after taking into consideration KOL viewpoints

 

Related Reports By DelveInsight:

Lupus Nephritis Market

DelveInsight’s Lupus Nephritis Market Insights, Epidemiology, and Market Forecast 2032’ report delivers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Lupus Nephritis Pipeline

DelveInsight’s, “Lupus Nephritis Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AstraZeneca’s SAPHNELO market size expected to increase many folds by 2032, report DelveInsight

ABVC BioPharma’s ABV-1504 market size expected to increase many folds by 2032, report DelveInsight

“ABV-1504 market”

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on ABV-1504 (ABVC BioPharma) providing insights into the drug market landscape and market forecast of ABV-1504 upto 2032. The report, titled “ ABV-1504 Market Size, Forecast, and Emerging Insight − 2032″ is now available for review and analysis.

Are you interested in finding out the projected market size of ABV-1504 in 2032? Click @ ABV-1504 Market Size

The ABV-1504 Market Report offers projected sales forecasts for ABV-1504 for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.

Do you know your drug’s competitive positioning against ABV-1504? Download Report: ABV-1504 Market Dynamics

ABVC BioPharma’s ABV-1504 is serving as a beacon of hope for the patients suffering from the Major Depressive Disorder. ABV-1504 is a promising pharmaceutical development primarily intended for the treatment of Major Depressive Disorder. This innovative drug operates through its unique mechanism of action as a Norepinephrine Transporter (NET) Inhibitor. The collaborative efforts behind ABV-1504 involve Stanford University in the United States and Taipei Veterans General Hospital in Taiwan. As of 2023, the drug has successfully completed Phase II Trial Part II and is poised to enter the crucial End of Phase II (EOP2) meeting with the FDA. Notably, ABV-1504 has secured patents in key countries such as the United States, the United Kingdom, Japan, Germany, France, Italy, China, and Taiwan. Its favorable toxicology profile, with negative genotoxicity and a NOAEL of 3,000mg/kg/day in rats and dogs, underscores its safety. The drug’s clinical journey includes the completion of a Phase II Clinical Study Report (CSR) in 2019, further supporting its potential efficacy and safety in the realm of depressive disorder treatment.

The report extensively covers the details and developments related to ABV-1504, capturing important highlights on developmental pipeline, regulatory status and special designations of ABV-1504, route of administration, safety and efficacy details.

ABV-1504 Market Assessment

This ABV-1504 market report provides a detailed market assessment of ABV-1504 for Major Depressive Disorder in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.

ABV-1504 Clinical Assessment

The report provides information related to clinical trials of ABV-1504 for Major Depressive Disorder covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related. 

ABV-1504 Competitive Landscape 

The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the ABV-1504.

ABV-1504 Market Size in the US

A dedicated section of the report focuses on the expected market size of ABV-1504 for the United States. DelveInsight’s analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.

What is a ABV-1504 Prescribed for?

ABV-1504 is prescribed for the treatment of Major Depressive Disorder.

Key Highlights of ABV-1504: 

  • The report contains forecasted sales of ABV-1504 for indication till 2032.
  • Comprehensive coverage of the late-stage emerging therapies for Major Depressive Disorder.
  • The report also features the qualitative and quantitative analysis with analysts as well as KOL views for ABV-1504 in Major Depressive Disorder.

Why you should buy ABV-1504 Market Report:

  • The report provides future market assessments for ABV-1504 for Major Depressive Disorder in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts’ views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
  • Leading ABV-1504 for Major Depressive Disorder forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the ABV-1504 
  • Discover the competitive landscape of ABV-1504 through 7MM
  • Get a Thorough Analysis of the ABV-1504 Development pipeline, Safety & Efficacy of the ABV-1504, and ROA
  • Thorough ABV-1504 market forecast will help understand how drug is competing with other emerging ABV-1504
  • Get analysis of the ABV-1504 clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
  • Drug Market forecasts are calculated after taking into consideration KOL viewpoints

Request for Sample Page @ https://www.delveinsight.com/sample-request/abv-1504-emerging-drug-insight-and-market-forecast

Related Reports By DelveInsight:

Major Depressive Disorder Market

DelveInsight’s Major Depressive Disorder Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the Major Depressive Disorder, historical and forecasted epidemiology as well as the Major Depressive Disorder market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Major Depressive Disorder Pipeline

DelveInsight’s, “Major Depressive Disorder Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: ABVC BioPharma’s ABV-1504 market size expected to increase many folds by 2032, report DelveInsight

Powering the Future: Hydrogen Energy Storage Market (2024-2032)

“Hydrogen Energy Storage Market Report and Forecast 2024-2032”
The hydrogen energy storage market revolves around the storage and utilization of hydrogen as an energy carrier.

Market Outlook

The market outlook for the hydrogen energy storage sector from 2024 to 2032 is exceptionally optimistic, driven by the global transition towards clean and sustainable energy solutions. With a projected Compound Annual Growth Rate (CAGR) of 5.60%, the market is poised for substantial expansion, aiming to reach a remarkable value of approximately USD 29.28 billion by 2032. As nations worldwide prioritize carbon emission reduction and the integration of renewable energy sources, hydrogen energy storage emerges as a pivotal player in addressing energy challenges and shaping a more sustainable future.


Size and Forecast

In 2023, the global hydrogen energy storage market size reached an approximate value of USD 17.95 billion. Forecasts indicate that this market will continue to flourish, with an expected CAGR of 5.60% during the forecast period of 2024-2032. By 2032, it is anticipated to soar to a value of around USD 29.28 billion.


Report Overview

The hydrogen energy storage market is at the heart of a clean energy revolution. This comprehensive report provides a deep dive into the market’s dynamics, offering valuable insights for stakeholders and investors. It encompasses a roadmap for understanding the market’s evolution from 2024 to 2032.


Definition

The hydrogen energy storage market revolves around the storage and utilization of hydrogen as an energy carrier. It plays a pivotal role in facilitating clean and sustainable energy solutions, contributing to the reduction of carbon emissions.


Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/hydrogen-energy-storage-market/requestsample


Segmentation Analysis

To gain a comprehensive understanding of the hydrogen energy storage market, it’s essential to explore its segmentation:

  • Technology: Segments include compressed hydrogen, liquid hydrogen, and hydrogen fuel cells.
  • Application: Key applications encompass power generation, transportation, and industrial processes.
  • End-users: Industries such as energy, transportation, and manufacturing are major end-users.

Key Developments

The hydrogen energy storage market has witnessed significant developments, including:

  • Advancements in hydrogen production technologies, making it more cost-effective.
  • Collaborations and partnerships between energy companies to scale up hydrogen storage projects.
  • Growing investments in research and development to improve hydrogen storage systems.

Market Trends in Hydrogen Energy Storage (2024-2032):

  1. Green Hydrogen Dominance: The market is witnessing a significant shift towards “green hydrogen,” produced using renewable energy sources such as wind and solar power. Green hydrogen is gaining prominence as it aligns with global sustainability goals and reduces carbon emissions.
  2. Energy Transition Initiatives: Governments and organizations worldwide are launching ambitious initiatives to accelerate the transition to hydrogen-based energy systems. These initiatives involve investments in research, infrastructure development, and policy support to promote hydrogen adoption.
  3. Electrolysis Advancements: Advancements in electrolysis technology are making hydrogen production more efficient and cost-effective. High-temperature and high-pressure electrolysis methods are gaining traction, improving overall hydrogen generation efficiency.
  4. Hydrogen Infrastructure Expansion: The expansion of hydrogen infrastructure, including production, storage, and distribution facilities, is a key trend. This expansion aims to support the growing demand for hydrogen as a clean energy carrier.
  5. Hydrogen in Heavy Industries: Heavy industries such as steel, chemicals, and transportation are increasingly adopting hydrogen as a means to decarbonize their processes. Hydrogen is used as a feedstock, fuel, and energy carrier in various industrial applications.

Reasons to Purchase this Report

Investing in understanding the hydrogen energy storage market is essential for various reasons:

 

  • In-depth Insights: Gain profound insights into market trends and opportunities.
  • Key Player Analysis: Analyze the strategies and positions of key players in the market.
  • Comprehensive Segmentation: Explore the market’s diverse segments for strategic decision-making.
  • Evaluation of Growth Prospects: Assess the market’s potential for growth and challenges.

Key Target Audience/Application

The hydrogen energy storage market caters to a diverse range of industries and professionals, including:

  • Energy Professionals: Those seeking clean energy solutions.
  • Manufacturing Experts: Engineers and technicians involved in process optimization.
  • Research and Development: Innovators in clean energy and hydrogen technology.

Impact of Covid-19

The Covid-19 pandemic has left an indelible mark on the hydrogen energy storage market. While initial disruptions affected production and supply chains, the recovery phase saw increased investments in clean energy solutions, including hydrogen storage, as countries aimed to build more resilient and sustainable energy systems. The pandemic underscored the importance of clean energy and the need for versatile energy storage solutions.

Key Players

Prominent players in the industrial automation and equipment market include:

  • Linde plc: Linde plc is a global leader in industrial gases and engineering, providing innovative solutions for a wide range of industries.
  • Air Products Inc.: Air Products Inc. specializes in providing atmospheric and process gases, equipment, and services to various industries worldwide.
  • ITM Power plc: ITM Power plc is a leading company in the development of hydrogen energy solutions, including electrolysis-based hydrogen production.
  • Dufresne Private Ltd: Dufresne Private Ltd is known for its expertise in the industrial automation sector, offering innovative solutions and services.
  • Worthington Industries, Inc.: Worthington Industries, Inc. is a diversified industrial company with a focus on steel processing and manufacturing.
  • Chart Industries, Inc.: Chart Industries, Inc. is a global manufacturer of equipment and systems for the production, storage, and distribution of cryogenic gases and energy solutions.

These industry leaders are at the forefront of innovation and technological advancements in the field of industrial automation and equipment.

FAQs

Q1: What is the projected growth rate of the hydrogen energy storage market from 2024 to 2032? A1: The hydrogen energy storage market is expected to grow at a CAGR of 5.60% during the forecast period of 2024-2032.

Q2: What is the significance of industrial automation and equipment in the modern industrial landscape? A2: Industrial automation and equipment play a crucial role in enhancing efficiency, productivity, and quality in various industries, from manufacturing to healthcare.

Q3: Who are some of the major players in the industrial automation and equipment market? A3: Key players include Siemens AG, ABB Group, Schneider Electric SE, Rockwell Automation, Inc., and Emerson Electric Co.

Q4: What are the key developments in the industrial automation and equipment sector? A4: Key developments include advancements in automation technologies, integration of industrial robots, and the growing emphasis on remote monitoring and control solutions.

Q5: How did the Covid-19 pandemic impact the industrial automation and equipment market? A5: The pandemic accelerated the adoption of automation and remote monitoring solutions to ensure business continuity and highlighted the importance of resilient industrial processes.

Q6: What industries and professionals benefit from the industrial automation and equipment market? A6: Industries such as manufacturing, healthcare, automotive, aerospace, and professionals including engineers, technicians, and researchers benefit from industrial automation and equipment solutions.

More Reports

Massive Open Online Course Market: https://bityl.co/NjsE

United States Golf Cart Market: https://bityl.co/NjsF

Wire and Cable Compounds Market: https://bityl.co/NjsH

Heated Humidifiers Market: https://bityl.co/NG8s

Big Data Technology Market:  https://bityl.co/NjsO

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.

Media Contact
Company Name: Expert Market Research
Contact Person: Matt Johnson
Email: Send Email
Phone: +1-415-325-5166
Address:30 North Gould Street
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Powering the Future: Hydrogen Energy Storage Market (2024-2032)

Global Real Estate Market is Anticipating a 5% CAGR Surge from 2024-2032, Due to Rising Population and Increased Demand for Premium Housing

“Global Real Estate Market Report and Forecast 2024-2032”
The real estate market is currently experiencing a period of robust growth, a trend that is expected to continue in the coming years. This expansion is primarily driven by a combination of factors, including increasing urbanization, a rising global population, and a growing middle class with higher disposable incomes.

Introduction

 

The real estate sector stands as a cornerstone of the global economy, weaving through various aspects of our daily lives. In recent years, the sector has been undergoing significant transformation and growth. As of now, the global real estate market is on a trajectory to expand at a Compound Annual Growth Rate (CAGR) of 5.00% from 2024 to 2032. This growth is primarily driven by an expanding global population, coupled with an increasing demand for high-quality housing and infrastructure. This blog post aims to delve into the intricacies of this market, exploring its various facets and the factors contributing to its growth, while also addressing the challenges and potential opportunities that lie ahead.

 

Market Overview: Current State and Future Projections

 

Market Size and Growth Projections

 

The current valuation of the global real estate market is substantial, reflecting its critical role in the world economy. With an anticipated CAGR of 5.00% between 2024 and 2032, the market is expected to witness significant expansion. This growth can be attributed to various factors, including urbanization, technological advancements, and evolving consumer preferences.

 

Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/real-estate-market/requestsample

 

Key Market Drivers

 

  • Urbanization and Population Growth: The ongoing trend of urbanization, coupled with population growth, is a key driver of real estate market expansion. As more people move to urban areas in search of employment and better living standards, the demand for residential as well as commercial properties is expected to rise.

 

  • Economic Development: Economic growth in emerging markets has led to increased disposable incomes, enabling more people to invest in real estate, either for personal use or as an investment.

 

  • Technological Innovations: The integration of technology in the real estate sector, such as through PropTech (Property Technology), is revolutionizing how properties are bought, sold, and managed, making the process more efficient and accessible.

 

Segment Analysis: Residential, Commercial, and Industrial Real Estate

 

Residential Real Estate

 

Residential real estate, encompassing housing for individuals, families, and groups, is a significant segment of the market. This segment’s growth is propelled by factors such as increasing urbanization, changing lifestyle patterns, and government initiatives in affordable housing.

 

Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/real-estate-market

 

Commercial Real Estate

 

Commercial real estate, which includes office spaces, retail outlets, and hospitality properties, is another vital segment. This sector is influenced by economic growth, corporate expansions, and the evolving nature of workspaces, especially post-COVID-19.

 

Industrial Real Estate

 

Industrial real estate, comprising manufacturing plants, warehouses, and distribution centers, has seen a surge in demand, particularly due to the growth of e-commerce and the need for efficient supply chain solutions.

 

Regional Insights: Key Markets and Emerging Economies

 

North America and Europe

 

These regions have traditionally been strongholds in the global real estate market, with a mature and stable environment. The focus here is on sustainable and smart infrastructure development.

 

Asia-Pacific

 

The Asia-Pacific region, particularly countries like China and India, is witnessing rapid real estate development due to fast-paced urbanization and economic growth.

 

Middle East and Africa

 

Emerging markets in the Middle East and Africa are experiencing growth in real estate, driven by government initiatives and investments in infrastructure development.

 

Trends Shaping the Future of Real Estate

 

Sustainable Development

 

Sustainability is becoming a central theme in real estate development, with a focus on eco-friendly materials, energy efficiency, and green building practices.

 

Smart Homes and Offices

 

The rise of smart technology is leading to the development of intelligent homes and office spaces, equipped with IoT devices for enhanced comfort, security, and efficiency.

 

The Impact of Remote Working

 

The shift towards remote work, accelerated by the COVID-19 pandemic, is reshaping the demand for office spaces and residential real estate.

 

Challenges and Opportunities

 

Market Challenges

 

The real estate sector faces several challenges, including regulatory hurdles, market volatility, and environmental concerns.

 

Opportunities for Growth

 

Despite these challenges, there are significant opportunities, such as the potential for innovative financing models, the untapped market in affordable housing, and the integration of digital technologies in real estate transactions.

 

Real Estate Market Trends: Navigating the Evolving Landscape

 

The real estate market is an ever-evolving entity, shaped by a myriad of factors ranging from economic shifts to technological advancements. As we navigate through the 2020s, several key trends have emerged, reflecting changes in consumer behavior, market dynamics, and broader societal shifts. Understanding these trends is crucial for investors, developers, real estate professionals, and consumers to make informed decisions. Let’s delve into some of the most significant real estate market trends currently shaping the industry.

 

Technology Integration: The Rise of PropTech

 

The integration of technology in real estate, known as PropTech, is revolutionizing how properties are bought, sold, managed, and experienced. This includes:

 

  • Virtual Reality (VR) and Augmented Reality (AR): For virtual tours and inspections, enhancing the buying experience.

 

  • Blockchain: Increasing transparency and efficiency in real estate transactions.

 

  • Artificial Intelligence (AI) and Big Data: For predictive analytics in market trends and consumer behavior.

 

Sustainable and Green Living

 

Sustainability is no longer a buzzword but a necessity. Green living and eco-friendly practices are becoming central to real estate development. This trend includes:

 

  • Energy-efficient Buildings: With a focus on reducing carbon footprints.

 

  • Green Spaces: Integrating nature into urban environments.

 

  • Sustainable Materials: Use in construction to minimize environmental impact.

 

Urbanization and the Rise of Smart Cities

 

Urbanization continues to be a driving force in real estate, with an increasing population moving to cities. This trend is fostering the development of smart cities, where technology is used to enhance the efficiency and quality of urban living. Smart cities feature:

 

  • Intelligent Transportation Systems

 

  • Smart Energy Management

 

  • Advanced Infrastructure

 

Shift Towards Remote Work and its Impact

 

The COVID-19 pandemic accelerated the trend of remote work, which has significant implications for the real estate market:

 

  • Changing Demand for Office Space: With businesses adopting hybrid work models.

 

  • Rise in Home Office Spaces: Influencing residential real estate design and location preferences.

 

The Growing Importance of E-Commerce

 

The rise of e-commerce is impacting the industrial and retail real estate sectors. This includes:

 

  • Increased Demand for Warehouses: For storage and distribution.

 

  • Evolution of Retail Spaces: Transforming into experience centers and pickup points.

 

Affordability Challenges and Innovative Solutions

 

Housing affordability remains a critical issue, leading to innovative solutions such as:

 

  • Co-living Spaces: Offering affordable and flexible living arrangements.

 

  • Government Initiatives: In affordable housing projects.

 

  • Alternative Financing Models: Like rent-to-own schemes.

 

Global Investment Flows

 

Real estate investment is becoming increasingly globalized, with cross-border investments growing. Investors are diversifying portfolios across regions, driven by:

 

  • Political Stability

 

  • Economic Growth Prospects

 

  • Market Maturity

 

Demographic Shifts and Changing Consumer Preferences

 

Changing demographics, such as an aging population and the rise of millennials, are influencing real estate trends:

 

  • Senior Living Facilities: Tailored to the needs of an aging population.

 

  • Millennial Preferences: For urban, tech-friendly, and flexible living spaces.

 

The Resurgence of Suburban Areas

 

There’s a growing interest in suburban real estate as people seek more space, comfort, and a better quality of life, especially in the context of remote work.

 

Real Estate Crowdfunding

 

Real estate crowdfunding platforms are democratizing investment, allowing smaller investors to participate in property investment opportunities.

 

Global Real Estate Market: Competitor Landscape

 

The major companies in the market are as follows:

 

  • Brookfield Asset Management Inc.

 

  • Prologis, Inc.

 

  • WANDA Group

 

  • SIMON PROPERTY GROUP, L.P.

 

  • Coldwell Banker Real Estate LLC

 

  • Savills plc

 

  • RE/MAX, LLC

 

  • CBRE Group

 

  • Sotheby’s International Realty Affiliates LLC

 

  • Colliers International Property Consultants, Inc.

 

  • GECINA Group

 

  • Others

 

Read More Trending Reports:

 

India Online Grocery Market

 

Loyalty Management Market

 

Latin America Palm Oil Market

 

South Korea Instant Coffee Market

 

North America Laminate Flooring Market

Media Contact
Company Name: Expert Market Research
Contact Person: Matt Johnson
Email: Send Email
Phone: +1-415-325-5166
Address:30 North Gould Street
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Global Real Estate Market is Anticipating a 5% CAGR Surge from 2024-2032, Due to Rising Population and Increased Demand for Premium Housing

Digital Holography Market Size, Share, Trends And Forecast To 2032

“Digital Holography Market”
Digital Holography Market By Offering (Hardware, Software), By Dimension (Two-dimensional (2D), Three-dimensional (3D)), By Application (Holographic Microscopy, Holographic Imaging, Holographic Telepresence, Others), By End-Use (Healthcare, Automotive, Aerospace &Defense, Education, Consumer Electronics, Entertainment, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The market for digital holography, an advanced technology utilized in the field of visualization and imaging, is anticipated to experience substantial expansion between 2023 and 2032. From 2024 to 2032, the market for digital holography is anticipated to expand at a CAGR of 18.5%, propelled by hardware technology advancements, the swift progression of 3D digital holography, and software innovations that facilitate improved functionality. On the other hand, substantial obstacles in the form of standardization and interoperability must be overcome to ensure the smooth incorporation of digital holography throughout various sectors. The market can be effectively segmented based on offering and dimension, which offers valuable insights into the relative importance of software and hardware components and the suitability of 2D and 3D technologies for various applications. From a geographical standpoint, the Asia-Pacific region assumes a pivotal role, which is indicative of the area’s strong focus on technological progress. It is anticipated that these market drivers, challenges, and competitive dynamics will persistently impact the digital holography market throughout the forecast period. As a result, this segment will continue to undergo significant transformation and development within the wider domain of imaging and visualization technologies.

The market for digital holography is driven by ongoing developments in hardware technologies. The advancement of digital holography systems has been facilitated by the development of various components and technologies, such as high-resolution sensors, efficient light sources, and sophisticated optical components. The aforementioned factor is emphasized by the growing allocation of resources towards research and development by prominent participants in the industry, which results in the release of cutting-edge hardware solutions. The implementation of digital holography systems that feature enhanced resolution, sensitivity, and real-time processing capabilities indicates that the market is currently undergoing a period of significant change propelled by an unwavering commitment to technological advancement.

The accelerated expansion of the digital holography market can be attributed to the development of 3D digital holography. The proliferation of 3D digital holography implementations in numerous sectors, including healthcare, automotive, and aerospace, is one indication of this. The increasing utilization of 3D holographic displays, holographic microscopy, and holographic imaging techniques in medical diagnostics, automotive design, and scientific research serves to emphasize this driver. The increasing need for 3D digital holography solutions to tackle intricate visualization obstacles and enhance accuracy across various industries is indicative of this factor that is anticipated to significantly contribute to the growth of the market between 2024 and 2032.

Browse for the report at: https://www.acutemarketreports.com/report/digital-holography-market

The market for digital holography is experiencing significant expansion due to advancements in software that improve its functionality. The evidence comprises the creation of sophisticated algorithms, software for processing data, and interfaces that are intuitive for users, all of which facilitate the extraction of significant information from holographic data. The integration of artificial intelligence and machine learning methodologies within digital holography software underscores this factor, as it enables the implementation of automated analysis and real-time visualization. The increasing focus on software developments to enhance hardware functionalities indicates that this factor is anticipated to influence the market by equipping users with robust instruments for comprehensive holographic data interpretation and analysis.

One significant factor impeding the growth of the digital holography industry is the difficulty in achieving standardization and interoperability. The presence of a wide range of digital holography technologies, file standards, and formats contributes to the complexity of the user environment and impedes smooth interoperability. The lack of universally recognized standards exacerbates this constraint, resulting in complications related to compatibility and restrictions on the transfer of holographic data between disparate systems. The imperative to resolve these obstacles is supported by the industry’s continuous endeavors to establish standardized protocols and standards; doing so is vital for promoting the extensive implementation and integration of digital holography technologies in a variety of contexts.

The hardware segment of the digital holography market generated significant revenue in 2023, encompassing holographic displays, sensors, and cameras. Concurrently, software offerings demonstrated the most substantial compound annual growth rate (CAGR) from 2024 to 2032, a sign that the increasing significance of software in enabling digital holography systems to reach their complete capabilities is being acknowledged. The aforementioned intricate segmentation demonstrates the equitable contribution of software and hardware elements to the expansion and development of the digital holography industry as a whole.

Download Free Sample Copy From https://www.acutemarketreports.com/request-free-sample/140081

In 2023, three-dimensional (3D) digital holography generated substantial revenue for the digital holography market, reflecting the rising demand for realistic and immersive holographic visualizations. Concurrently, the CAGR for two-dimensional (2D) digital holography was the highest throughout the forecast, indicating its significance in applications that demand both accuracy and simplicity. The aforementioned thorough segmentation underscores the wide-ranging applications and inclinations present in the digital holography market. Particularly, industry demands and user preferences are catered to by 2D and 3D technologies.

The digital holography market demonstrated dynamic trends on a geographical level in 2023, with the Asia-Pacific region accounting for the majority of revenue generation and boasting the highest CAGR. This observation signifies the region’s notable emphasis on technological progress, research and development endeavors, and the expanding implementation of digital holography throughout various sectors. Revenue was also substantially influenced by North America, where a mature technology landscape and the presence of major industry players played a significant role. Europe, despite showcasing a resilient market, witnessed a marginally diminished CAGR, which can be attributed to the well-established status of the technology within the area. The geographical division of this market highlights the worldwide scope of the digital holography industry, wherein various regions exert unique influences on its development.

Prominent industry participants, including Sony Corporation, Leia Inc., RealView Imaging Ltd., Lyncee TEC SA, Phase Holographic Imaging AB (PHI), EON Reality, Inc., Holmarc Opto-Mechatronics, Holotech Switzerland AG, Geola Digital Uab, Ovizio imaging systems, RealFiction, Himax Technologies, Inc., MetroLaser, Hypervsn, Vividq Ltd, Samsung and Meta, significantly influence the direction of the digital holography market. Market dynamics have been substantially impacted by the extensive portfolios, global presence, and strategic initiatives of these industry leaders. The aforementioned firms exhibited robust financial performance in 2023, and their ongoing commitments to R&D, collaborations, and partnerships establish them as pivotal drivers of the market’s expansion. In the period between 2024 and 2032, when the digital holography market is anticipated to enter its forecast phase, these market leaders are anticipated to maintain their dominance and exert significant influence over the market’s trajectory.

For business-related news: https://www.mobilecomputingtoday.co.uk/business/

Media Contact
Company Name: Acute Market Reports, Inc.
Contact Person: Chris Paul
Email: Send Email
Phone: US/Canada: +1-855-455-8662, India: +91 7755981103
Address:90 Church St, FL 1 #3514, New York, NY 10008, USA
City: New York
State: New York
Country: United States
Website: www.acutemarketreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Holography Market Size, Share, Trends And Forecast To 2032

The Brenda O’Brien Team Helps Beneficiaries Sell Inherited Homes with Compassion and Expertise

Dealing with the sale of an inherited home can be an emotional and challenging process. The Brenda O’Brien Team, a leading real estate agency in Oro Valley Arizona, is proud to announce their specialized services designed to assist beneficiaries in selling inherited homes with compassion and expertise.

Selling a parent’s home, especially when it involves being an out-of-town seller, can be a daunting task. The Brenda O’Brien Team understands the unique challenges faced by beneficiaries in such situations and offers a combination of real estate experience and genuine compassion to guide them through the process.

Roanne from CA said “Brenda was absolutely the angel we needed to expedite everything we needed to get done for our sister’s estate. She not only handled the real estate sale with finesse, it sold day one on the market with three offers and closed 30 days later, but her efforts went way beyond what one would expect. She was invaluable in many ways, having to organize this from a different state. Due to her help, we were able to hire an estate sales company, attorney, repair man, cleaning service, and she met roofers and got estimates. We can’t thank her enough for making a difficult situation absolutely manageable.”

As a team of seasoned Realtors in Oro Valley AZ, The Brenda O’Brien Team recognizes that selling an inherited property goes beyond just the transaction. It’s about helping families navigate an emotionally charged time while ensuring a smooth and efficient sale. With their comprehensive knowledge of the local real estate market, they are well-equipped to assist beneficiaries in making informed decisions about the sale of inherited properties.

Key services provided by The Brenda O’Brien Team for beneficiaries selling inherited homes include:

  1. Expert Market Analysis: The team conducts a thorough analysis of the local real estate market to determine the property’s current market value, helping beneficiaries set a competitive selling price.

  2. Guidance Through Legalities: The Brenda O’Brien Team assists beneficiaries in understanding and navigating the legal requirements and complexities involved in selling an inherited home.

  3. Preparing the Property: They offer recommendations on how to present the property in the best possible light to attract potential buyers.

  4. Compassionate Support: The team understands the emotional toll that selling an inherited home can take. They provide compassionate support and are there every step of the way to answer questions and alleviate concerns.

  5. Marketing Expertise: Leveraging their marketing expertise, they create tailored marketing strategies to reach a wider audience of potential buyers.

  6. Negotiation Skills: With their negotiation skills, The Brenda O’Brien Team strives to secure the best possible deal for beneficiaries.

  7. Seamless Transaction: They ensure a smooth and hassle-free transaction process from start to finish.

The Brenda O’Brien Team has a proven track record of assisting beneficiaries with the sale of inherited homes, helping families transition through this challenging time with care and professionalism.

For more information about the Brenda O’Brien Team and their real estate services in Oro Valley AZ, please visit www.BrendaOBrienTeam.com.

Media Contact:

Brenda O’Brien, Associate Broker, Realtor®,

Vice President Member of the Executive Council 

& Platinum Level 1926 Circle of Excellence 

Long Realty Company

Brenda@BrendaOBrienTeam.com

520-906-2897

About the Brenda O’Brien Team

The Brenda O’Brien Team is a leading real estate agency in Oro Valley, AZ, specializing in buyer and seller representation. With a deep understanding of the local market and a commitment to excellence, the team has earned a reputation as the top-ranked local real estate agents in the area. Their personalized approach, market expertise, and exceptional customer service have made them a trusted partner for clients seeking to navigate the complexities of buying and selling homes in Oro Valley, AZ.

Media Contact
Company Name: Brenda O’Brien Team
Contact Person: Brenda O’Brien
Email: Send Email
Country: United States
Website: brendaobrienteam.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Brenda O\’Brien Team Helps Beneficiaries Sell Inherited Homes with Compassion and Expertise

Revving Up for 2024: Total Automotive Sales to Cross 96 million units in 2024, post strong recovery in the year 2023

According to a research report, “Global Automotive Industry Outlook 2024 ” published by MarketsandMarkets, the global automotive sales is estimated to grow from over 91 million units in 2023 to cross 96 million units by 2024 at a steady Y-o-Y growth rate of 5-7% backed by strong recovery in commercial vehicles and electrification trend in passenger cars.

According to a research report, “Global Automotive Industry Outlook 2024 ” published by MarketsandMarkets, the global automotive sales is estimated to grow from over 91 million units in 2023 to cross 96 million units by 2024 at a steady Y-o-Y growth rate of 5-7% backed by strong recovery in commercial vehicles and electrification trend in passenger cars. The new research report discusses range of ongoing trends ranging from China’s EV Dominance to the ‘Amazonification’ of Vehicle Sales and Smart

Despite persistent geopolitical tensions and economic uncertainties, the global automotive industry has exhibited robust growth throughout 2023. Overall, sales volumes within the automotive sector expanded by 10-15% during this period to cross 91 million units, with both the passenger vehicle and commercial vehicle segments experiencing commendable growth. The commercial vehicles segment demonstrated a growth of 18-20% in 2023 over the previous year. Strong economic growth and increase in infrastructure projects led the commercial vehicle sales growth in Asia Pacific, particularly China and India. The electric passenger cars segment registered a growth of over 35% in 2023 as compared to the previous year.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77960341

Challenges such as geopolitical tensions, escalating commodity prices, and increasing interest rates are expected to impede markets in North America and Europe. Nonetheless, the Asia Pacific region is anticipated to surge forward, driven by the presence of major growing economies and sizable automotive markets, particularly in China and India.

Within the passenger vehicle segment, SUVs have consistently demonstrated substantial growth across various regions in recent years, a trend that has persisted into 2023 and is expected to continue in 2024. Notably, China stands out as the dominant market in the passenger vehicle segment, with other significant markets including the USA, India, Japan, and Germany.

Some of the key developments witnessed by automotive industry in 2023:

1. In 2023, the electric Vehicles market was impacted by the price cuts, increase in labor costs, production cuts and rise in interest rates.

2. While the industry talks about electrification, the fossil fuel powertrains i.e., the ICE vehicles continued to maintain healthy sales volumes.

3. Chinese OEMs and EV models are making significant inroads in the European EV market. Chinese automakers’ share of the Western European EV market has risen to 8-10%, a growth from 5-7% in the previous year

4. Collaborations between OEMs and Tech Companies: More collaborations between OEMs and tech companies is likely to drive innovation and growth in the automotive industry. For instance, in September 2023, Qualcomm Technologies, Inc. (US) collaborated with Mercedes-Benz AG to power vehicles with snapdragon digital chassis solutions.

Key Market Players

Within the realm of passenger vehicles, prominent original equipment manufacturers (OEMs) include Toyota, GM, Stellantis, Honda, Volkswagen, Nissan, BMW, Daimler, Tesla, and Ford. Notably, Tesla, BYD, Volkswagen, SAIC, and Stellantis stand out as key players in the electric passenger vehicle sector. Shifting the focus to commercial vehicles in 2023, the leading OEMs encompass Mercedes-Benz, Tata Motors, Traton, Paccar, Volvo, IVECO, Ashok Leyland, and Hino.

EV Sales Growth Hit the Brakes in 2024

While electric vehicle (EV) sales are on the rise across most markets, the pace of growth is decelerating. Although global sales volumes are projected to increase from 12-14 million units in 2023 to 15-17 million units in 2024, the surge is showing signs of plateauing. China is anticipated to contribute the largest share, reaching approximately 9-10 million units in 2024. However, the overall growth trajectory is slowing down. For instance, in the United States, the year-on-year growth of EV sales is expected to be a modest 15-20%, a notable decrease from the 55-60% observed in 2023. In China, the growth is also anticipated to be impacted by a reduction in incentives.

The slowdown in EV sales has prompted original equipment manufacturers (OEMs) to make strategic adjustments, including production cuts (e.g., GM, VW), delayed model launches (e.g., Audi, Ford), and the temporary halt of plans for new EV plants (e.g., Ford). In contrast to battery electric vehicles (BEVs), plug-in hybrid electric vehicles (PHEVs) are experiencing stronger sales growth. With reduced upfront costs, a lower total cost of ownership compared to internal combustion engine (ICE) vehicles, and the added benefit of flexibility (addressing range anxiety), PHEVs are emerging as a more compelling choice for consumers.

Some of the other key trends that the automotive industry is likely to witness in 2024:

1. China Continues to Dominate EV Market: China’s colossal domestic EV market, robust supply chain, innovations by OEMs as well as battery manufacturers and expansion in international markets (especially Europe) solidifies its role as a pivotal global EV player. China would continue to have a dominant share (over 50%) of the global EV market.

2. Amazonification’ of Vehicle Sales:  The evolving consumer demographics are driving a shift in the automotive industry, prompting OEMs to adopt new approaches, particularly emphasizing online sales, with the Asia Pacific region, being the youngest, poised for substantial volume growth. In key regions, the penetration of online sales would reach 10-20% in 2024.

3. Gigacasting & Smart Manufacturing Drive Innovation: Smart manufacturing approaches will permeate entire automotive value chain, enhancing overall efficiency and providing a seamless experience. More OEMs would operationalize Giga Casting in 2024. Digital tool integration will boost profitability and sustainability, transforming the manufacturing landscape significantly.

4. Level 3 Autonomous Vehicles: Level 3 vehicle segment to gain share in the market owing to the approvals received by Mercedes-Benz in US and Germany for L3 autonomy.

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=77960341

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/global-automotive-industry-outlook-77960341.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Revving Up for 2024: Total Automotive Sales to Cross 96 million units in 2024, post strong recovery in the year 2023

Rail Asset Management Market Growth, Opportunities Business Scenario, Share, Growth Size, Scope, Key Segments and Forecast to 2026

“Siemens (Germany), Alstom (France), Hitachi (Japan), Wabtec (US), IBM (US), SAP (Germany), Capgemini (France), Cisco (US), Huawei (China), Accenture (Ireland), Trimble (US), Bentley Systems (US), Atkins (UK), DXC (US), Trapeze Group (Canada), Tego (US), KONUX (Germany), L&T Technology Services (India), Assetic (Australia), and WSP (Canada).”
Rail Asset Management Market by Offering (Solutions (Condition Monitoring, Predictive Maintenance, Security, Asset Planning & Scheduling) and Services), Application (Rolling Stock and Infrastructure), Deployment Mode and Region – Global Forecast to 2026

The global rail asset management market size is expected to grow from USD 10.1 billion in 2021 to USD 13.2 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period. The rail industry plays a vital role in shaping the economic and financial position of a country. It carries billions of passengers and freights daily and generates huge revenues. Due to the ease and comfort in transportation, the dependence on railways for both passengers and goods is rising at a rapid pace. A majority of countries are investing heavily in rail infrastructure to provide a seamless experience to their citizens through railways. Railways also help governments minimize the cost of transfer of passengers as well as goods, considering the huge carrying capacity it offers in a single run. The growing dependence on railways is increasing the pressure on the existing rail infrastructure. This leads to several uncalled and unscheduled maintenance for both rolling stock and infrastructure, owing to wear and tear of systems, breakdowns, damages, and repair needs.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222416351

The solutions segment to hold a larger market size during the forecast period

Based on offering, the solutions segment of the rail asset management market is projected to hold a larger market size during the forecast period. The solutions segment in the rail asset management market is further segmented into asset performance management, analytics, asset planning and scheduling, security, workforce management, network management, and others (incident management, warranty management, and material management). The incorporation of various asset management solutions for the railway industry enables rail organizations to improve the complete asset lifecycle of both rolling stock and rail infrastructure.

By application, the infrastructure segment to record a higher growth rate during the forecast period

Railway infrastructure includes various systems, such as earthworks, bridges, tunnels, steelwork, timber, and track systems that form the base upon which the railway runs. The asset management system can enhance the efficiency and safety of these systems. Asset management comprises all systems, procedures, and tools that maximize asset availability for a minimum whole-life cost and risk, some of the activities in infrastructure asset management include route plans that involve activities, resources, and timescales for interventions on the infrastructure, detailed plans to optimize the delivery of renewals maintenance, and enhancement. Many rail operators are investing significantly in the rail infrastructure.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=222416351

Unique Features in the Rail Asset Management Market

Systems for managing rail assets, such as locomotives, carriages, and other rail vehicles, offer features for thorough rolling stock management, including lifecycle planning, maintenance, and inspections.

By using predictive maintenance technologies, railway operators can foresee probable malfunctions in parts like brakes, wheels, and signalling systems. Reliability is increased and downtime is reduced with this proactive strategy.

Rail asset management systems track assets and keep an eye on the whereabouts and movements of rolling stock by utilising asset tracking technologies and GIS data. This helps to maximise asset utilisation and guarantees real-time visibility.

Workflows for maintenance are customised to meet the unique requirements of rail systems and take industry norms and laws into account. For rail assets, this includes routine maintenance, inspections, and compliance audits.

In order to reduce delays and improve overall service delivery, Rail Asset Management connects with wider rail operations, coordinating maintenance schedules with operating plans.

Major Highlights of the Rail Asset Management Market

Predictive maintenance solutions have witnessed a notable shift in the rail asset management business. In order to anticipate possible rail asset breakdowns and minimise downtime while increasing maintenance efficiency, advanced analytics and sensor technologies are used.

The use of sensors and Internet of Things (IoT) devices in rail asset management has gained popularity. By offering real-time data on the state and functionality of rail assets, these solutions promote proactive maintenance and increase overall reliability.

The maintenance of rail infrastructure, such as tracks, switches, bridges, and signalling systems, is receiving more attention. Comprehensive tools for rail infrastructure monitoring, maintenance, and optimisation are included in rail asset management packages.

The optimisation of rolling stock is becoming more and more important to rail operators. The efficient planning of maintenance tasks, inspections, and repairs for locomotives, carriages, and other rolling stock is made possible by asset management systems.

The use of cloud-based rail asset management systems is growing in popularity. Rail operators may manage assets more efficiently thanks to cloud deployment’s scalability, accessibility, and data centralization capabilities.

Inquire Before Buying@ https://marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=222416351

Top Key Companies in the Rail Asset Management Market

The key and emerging market players in the rail asset management market include Siemens (Germany), Alstom (France), Hitachi (Japan), Wabtec (US), IBM (US), SAP (Germany), Capgemini (France), Cisco (US), Huawei (China), Accenture (Ireland), Trimble (US), Bentley Systems (US), Atkins (UK), DXC (US), Trapeze Group (Canada), Tego (US), KONUX (Germany), L&T Technology Services (India), Cyient (India), Assetic (Australia), Machines With Vision (UK), Uptake (US), Delphisonic (US), ZEDAS (Germany), OXplus (Netherlands), and WSP (Canada).These players have adopted various strategies to grow in the global rail asset management market.

Siemens is a leading vendor in the rail asset management market. The company offers rail, road, and intermodal solutions for enhancing the existing transportation systems under the Siemens Mobility division. Siemens offers a robust solution portfolio for railway operations. In the rail asset management market, the company offers its key mobility services called Railigent. Railigent helps railway companies manage assets better and smarter by using predictive maintenance, helping them reduce life cycle costs through extended service and maintenance intervals. It allows condition-based monitoring that enables trains and infrastructure to become more intelligent, leading to greater efficiency. The Railigent open ecosystem offers more comprehensive asset management by integrating in-house and third-party applications.

Hitachi is a leading provider of railway solutions to the Japanese and global railway operators. Through the constant development, Hitachi Rail STS S.p.A, a Hitachi subsidiary operating in the railway systems business, continues to introduce the newest technologies in asset management. Hitachi offers the Hitachi Predictive Maintenance solutions in the rail asset management market. The solutions include rolling stock and early anomaly detection. Hitachi’s Predictive Maintenance solutions enable customers to deploy sustainable and repeatable maintenance solutions and an optimized asset life cycle maintenance plan. These solutions help increase efficiency by providing timely decision-making capabilities and environmental sustainability through the continuous monitoring of rolling stock and the rail infrastructure. The company offers services and solutions for public safety, renewable and sustainable energy, intelligent transportation, precision agriculture and manufacturing, and water treatment and building systems to its customers.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/rail-asset-management-market-222416351.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rail Asset Management Market Growth, Opportunities Business Scenario, Share, Growth Size, Scope, Key Segments and Forecast to 2026